台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    27.70
  • 漲跌
    ▼0.10
  • 漲幅
    -0.36%
  • 成交量
    744
  • 產業
    上市 生技醫療類股
  • 635人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/25     後一日»

券商獲利排行 - 2024/03/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.96%79.6-0.179.799100126.926.926.827.7
  3.16%4814743571426.626.626.727.7
  3.43%35.8035.83939026.826.8027.7
  2.95%33.8-2.336.13743626.726.726.427.7
  0.96%24.79.415.316968026.826.726.927.7
  3.07%23-0.623.72428326.726.826.527.7
  3.75%200202020026.726.7027.7
  3.58%19.10.1191820126.726.726.827.7
  3.08%13.20.412.71216426.726.626.827.7
  4.14%110111010026.626.6027.7
  4.40%10.5010.599026.526.5027.7
  3.66%6.906.977026.726.7027.7
  4.14%5.505.555026.626.6027.7
  3.36%5.405.466026.826.8027.7
  3.94%5.305.355026.726.7027.7
  3.94%5.305.355026.726.7027.7
  3.94%5.305.355026.726.7027.7
  1.26%4400121226.726.626.927.7
  3.75%40444026.726.7027.7
  3.70%40444026.726.7027.7
  3.36%3.603.644026.826.8027.7
  4.53%3.603.633026.526.5027.7
  3.62%2.902.933026.726.7027.7
  2.13%2.902.935226.826.826.827.7
  3.36%2.702.733026.826.8027.7
  3.17%2.602.633026.926.9027.7
  4.53%2.402.422026.526.5027.7
  3.94%2.102.122026.726.7027.7
  3.94%2.102.122026.726.7027.7
  3.84%2.102.122026.726.7027.7
  3.75%20222026.726.7027.7
  3.55%1.901.922026.826.8027.7
  3.55%1.901.922026.826.8027.7
  3.36%1.801.822026.826.8027.7
  3.36%1.801.822026.826.8027.7
  3.36%1.801.822026.826.8027.7
  3.36%1.801.822026.826.8027.7
  3.17%1.701.722026.926.9027.7
  3.17%1.701.722026.926.9027.7
  2.54%1.40.21.202126.626.626.827.7
  5.12%1.401.411026.426.4027.7
  2.54%1.40.11.212126.626.526.727.7
  5.12%1.401.411026.426.4027.7
  5.12%1.401.411026.426.4027.7
  5.12%1.301.311026.426.4027.7
  2.25%1.20.21.112126.726.726.827.7
  4.51%1.201.211026.526.5027.7
  4.14%1.101.111026.626.6027.7
  4.14%1.101.111026.626.6027.7
  2.07%1.101.112126.626.626.627.7

券商虧損排行 - 2024/03/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -2.86%-44.92.3-47.1-42165926.626.526.627.7
  -3.36%-270-27-3003026.8026.827.7
  -3.92%-230-23-2202226.7026.727.7
  -3.61%-15.50-15.5-1501626.726.626.727.7
  -4.33%-150-15-1301326.6026.627.7
  -3.73%-14.90-14.9-1501526.726.626.727.7
  -4.14%-110-11-1001026.6026.627.7
  -3.57%-10.50-10.5-1101126.7026.727.7
  -3.74%-100-10-1001026.726.626.727.7
  -3.69%-9.90-9.9-901026.726.826.727.7
  -3.56%-9.5-0.1-9.5-911026.726.726.727.7
  -3.05%-90-9-1101126.926.926.927.7
  -3.75%-80-8-80826.7026.727.7
  -2.55%-7.50.3-7.8-831126.726.626.727.7
  -3.91%-7.30-7.3-60726.726.626.727.7
  -3.88%-7.30-7.3-70726.7026.727.7
  -3.86%-7.20-7.2-70726.7026.727.7
  -3.77%-7.10-7.1-70726.7026.727.7
  -3.75%-70-7-70726.7026.727.7
  -3.61%-6.80-6.8-70726.7026.727.7
  -3.58%-6.70-6.7-70726.7026.727.7
  -3.47%-6.50-6.5-70726.8026.827.7
  -3.47%-6.50-6.5-70726.8026.827.7
  -3.88%-6.20-6.2-60626.7026.727.7
  -3.94%-5.30-5.3-50526.7026.727.7
  -3.94%-5.30-5.3-40526.726.926.727.7
  -2.01%-4.8-0.9-3.9-35926.826.926.727.7
  -4.43%-4.70-4.7-30426.526.826.527.7
  -3.36%-4.50-4.5-50526.8026.827.7
  -3.36%-4.50-4.5-40526.826.626.827.7
  -3.36%-4.50-4.5-50526.8026.827.7
  -3.36%-4.50-4.5-50526.8026.827.7
  -4.09%-4.40-4.4-40426.6026.627.7
  -3.07%-4.1-0.1-4-41526.726.826.727.7
  -3.70%-40-4-40426.7026.727.7
  -3.55%-3.80-3.8-40426.8026.827.7
  -4.14%-3.30-3.3-30326.6026.627.7
  -2.44%-3.2-0.1-3.2-22526.726.726.727.7
  -3.94%-3.20-3.2-30326.7026.727.7
  -3.94%-3.20-3.2-30326.7026.727.7
  -3.81%-3.10-3.1-30326.7026.727.7
  -3.75%-30-3-30326.7026.727.7
  -3.55%-2.90-2.9-20326.726.626.827.7
  -3.42%-2.70-2.7-30326.8026.827.7
  -3.36%-2.70-2.7-30326.8026.827.7
  -3.36%-2.70-2.7-30326.8026.827.7
  -3.36%-2.70-2.7-30326.8026.827.7
  -1.64%-2.20.4-2.6-32526.826.726.927.7
  -4.14%-2.20-2.2-20226.6026.627.7
  -3.94%-2.10-2.1-20226.7026.727.7
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章